Iproteos

based on the technology transfer from IRB Barcelona and the University of Barcelona.

Iproteos is a biotech company that focuses its activity on the R&D of new therapeutic strategies based on modulation of protein-ligand (PLI) and protein-protein interactions (PPIs) through peptidomimetics. The novel entities are obtained thanks to the IPRO technology, an innovative platform. Specifically, at Iproteos we apply the IPRO technology on the search for therapeutic agents for the treatment of diseases of the central nervous system (CNS). Based on our expertise in the field, Iproteos is your perfect partner in the discovery of potent and active peptidomimetics for your own targets.